Spotlight on China: A dominant player in the clinical trial landscape

Published on November 28, 2024

In a series exploring trends across the APAC region, Norstella’s subject matter experts from key biopharma hubs delve into this year’s standout developments and share their outlook for 2025. China’s booming clinical trial landscape continues to grow and diversify with greater investment from Big Pharma in addition to new promising modalities at play. In our […]

Continue reading on website
Other news

San Diego Business Journal: Abzena Completes Major Lab Expansion

November 26, 2024
In October we completed a a major microbiology lab expansion to support our quality control and stability testing capabilities at our Sorrento Valley, San Diego development and manufacturing site.The construction of our new 900 square foot lab space was finished in October. It is located at our state-of-the-art biologic GMP manufacturing facility located on Lusk Boulevard in Sorrento Valley, San D

Development and characterization of iPSC-derived regulatory T cells – Towards an allogenic cell therapy for the treatment of autoimmunity and inflammatory conditions

December 3, 2024
Regulatory T cells (Tregs) play a pivotal role in maintaining immune homeostasis and preventing autoimmunity. Treg-based cell therapies have already shown efficient modulation of immune responses in several clinical settings. However, the complexity and the cost of manufacturing autologous cell products restricts their implementation to certain patient populations with the highest unmet need. Indu